Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin

The Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM (European Directorate for the Quality of Medici...

Full description

Saved in:
Bibliographic Details
Main Authors: Simona Sturzu, Daniela Tîrsînoagă, Ioana Tihulcă, Mariana Dumitrache, Alina Drăghici, Valentina Năstase
Format: Article
Language:English
Published: Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar 2015-12-01
Series:Medicamentul Veterinar
Online Access:http://www.veterinarypharmacon.com/docs/1600-2015_VD2_Art.8_ENG..pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839604673382711296
author Simona Sturzu
Daniela Tîrsînoagă
Ioana Tihulcă
Mariana Dumitrache
Alina Drăghici
Valentina Năstase
author_facet Simona Sturzu
Daniela Tîrsînoagă
Ioana Tihulcă
Mariana Dumitrache
Alina Drăghici
Valentina Năstase
author_sort Simona Sturzu
collection DOAJ
description The Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM (European Directorate for the Quality of Medicines) - coordinating of the study. The purpose of the study was to establish the potency of the batch 4 rifamycin in the characterization of the substance as reference standard. Potency was determined by microbiological method, based on comparison of the inhibition zones of growth of micro-organisms sensitive to those of a reference standard, as specified in European Pharmacopoeia, Chapter 2.7.2. - Microbiological testing of antibiotics. After analysis of received data from participants and their statistical processing by the EDQM, the potency of the batch 4, rifamycin - reference materials, was established in 870 UI/mg.
format Article
id doaj-art-199853ab52d24d8c84b5764a9ec0cae6
institution Matheson Library
issn 1843-9527
2069-2463
language English
publishDate 2015-12-01
publisher Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar
record_format Article
series Medicamentul Veterinar
spelling doaj-art-199853ab52d24d8c84b5764a9ec0cae62025-08-02T02:28:20ZengAsociaţia Naţională a Fabricanţilor de Produse de Uz VeterinarMedicamentul Veterinar1843-95272069-24632015-12-01927779Report concerning the colaborative study for establish of reference standard eficacity of RifamycinSimona Sturzu0Daniela Tîrsînoagă1Ioana Tihulcă2Mariana Dumitrache3Alina Drăghici4Valentina Năstase 5Institute for Control of Veterinary Biological Products and Medicines Bucharest Institute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestThe Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM (European Directorate for the Quality of Medicines) - coordinating of the study. The purpose of the study was to establish the potency of the batch 4 rifamycin in the characterization of the substance as reference standard. Potency was determined by microbiological method, based on comparison of the inhibition zones of growth of micro-organisms sensitive to those of a reference standard, as specified in European Pharmacopoeia, Chapter 2.7.2. - Microbiological testing of antibiotics. After analysis of received data from participants and their statistical processing by the EDQM, the potency of the batch 4, rifamycin - reference materials, was established in 870 UI/mg.http://www.veterinarypharmacon.com/docs/1600-2015_VD2_Art.8_ENG..pdf
spellingShingle Simona Sturzu
Daniela Tîrsînoagă
Ioana Tihulcă
Mariana Dumitrache
Alina Drăghici
Valentina Năstase
Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin
Medicamentul Veterinar
title Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin
title_full Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin
title_fullStr Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin
title_full_unstemmed Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin
title_short Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin
title_sort report concerning the colaborative study for establish of reference standard eficacity of rifamycin
url http://www.veterinarypharmacon.com/docs/1600-2015_VD2_Art.8_ENG..pdf
work_keys_str_mv AT simonasturzu reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin
AT danielatirsinoaga reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin
AT ioanatihulca reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin
AT marianadumitrache reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin
AT alinadraghici reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin
AT valentinanastase reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin